CVS Health Corporation $CVS Shares Sold by Capital City Trust Co. FL

Capital City Trust Co. FL decreased its holdings in shares of CVS Health Corporation (NYSE:CVS) by 20.7% during the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 3,294 shares of the pharmacy operator’s stock after selling 858 shares during the quarter. Capital City Trust Co. FL’s holdings in CVS Health were worth $227,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently bought and sold shares of the company. Clarius Group LLC grew its position in CVS Health by 13.1% in the 2nd quarter. Clarius Group LLC now owns 3,611 shares of the pharmacy operator’s stock worth $249,000 after purchasing an additional 418 shares during the last quarter. QRG Capital Management Inc. grew its position in CVS Health by 173.9% in the 2nd quarter. QRG Capital Management Inc. now owns 92,896 shares of the pharmacy operator’s stock worth $6,408,000 after purchasing an additional 58,984 shares during the last quarter. Boyar Asset Management Inc. grew its position in CVS Health by 1.9% in the 2nd quarter. Boyar Asset Management Inc. now owns 18,779 shares of the pharmacy operator’s stock worth $1,295,000 after purchasing an additional 345 shares during the last quarter. Stock Yards Bank & Trust Co. grew its position in CVS Health by 33.2% in the 2nd quarter. Stock Yards Bank & Trust Co. now owns 34,955 shares of the pharmacy operator’s stock worth $2,411,000 after purchasing an additional 8,716 shares during the last quarter. Finally, HighMark Wealth Management LLC grew its position in CVS Health by 266.9% in the 2nd quarter. HighMark Wealth Management LLC now owns 1,897 shares of the pharmacy operator’s stock worth $131,000 after purchasing an additional 1,380 shares during the last quarter. Institutional investors own 80.66% of the company’s stock.

CVS Health Stock Up 0.1%

CVS stock opened at $77.51 on Friday. CVS Health Corporation has a 12 month low of $43.56 and a 12 month high of $79.20. The firm has a market cap of $98.31 billion, a PE ratio of 21.65, a P/E/G ratio of 0.85 and a beta of 0.60. The firm has a 50 day simple moving average of $70.71 and a 200 day simple moving average of $67.33. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.80 and a quick ratio of 0.62.

CVS Health (NYSE:CVS) last released its earnings results on Thursday, July 31st. The pharmacy operator reported $1.81 EPS for the quarter, beating the consensus estimate of $1.46 by $0.35. CVS Health had a net margin of 1.17% and a return on equity of 10.51%. The business had revenue of $98.92 billion during the quarter, compared to analyst estimates of $94.87 billion. During the same period in the prior year, the business earned $1.83 earnings per share. The business’s quarterly revenue was up 8.4% on a year-over-year basis. CVS Health has set its FY 2025 guidance at 6.300-6.400 EPS. Equities research analysts forecast that CVS Health Corporation will post 5.89 earnings per share for the current fiscal year.

CVS Health Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Monday, November 3rd. Investors of record on Thursday, October 23rd will be given a $0.665 dividend. This represents a $2.66 annualized dividend and a dividend yield of 3.4%. The ex-dividend date is Thursday, October 23rd. CVS Health’s dividend payout ratio is 74.30%.

Analyst Upgrades and Downgrades

Several research analysts have commented on the stock. Zacks Research cut shares of CVS Health from a “strong-buy” rating to a “hold” rating in a research report on Monday, September 8th. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of CVS Health in a research note on Saturday, September 27th. Barclays upped their price target on shares of CVS Health from $80.00 to $87.00 and gave the stock an “overweight” rating in a research note on Thursday, September 4th. Jefferies Financial Group upped their price target on shares of CVS Health from $74.00 to $80.00 and gave the stock a “buy” rating in a research note on Monday, June 30th. Finally, UBS Group raised shares of CVS Health from a “neutral” rating to a “buy” rating and upped their price target for the stock from $67.00 to $79.00 in a research note on Monday, August 18th. Two research analysts have rated the stock with a Strong Buy rating, nineteen have given a Buy rating and four have issued a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average target price of $78.25.

Insider Activity at CVS Health

In related news, Director Anne A. Finucane sold 7,500 shares of the company’s stock in a transaction that occurred on Wednesday, August 20th. The shares were sold at an average price of $71.02, for a total value of $532,650.00. Following the completion of the sale, the director owned 22,156 shares in the company, valued at approximately $1,573,519.12. This represents a 25.29% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Company insiders own 1.22% of the company’s stock.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.